Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 332 are a BUY (88.53%), 43 are a HOLD (11.47%).
Analyst Emily Bodnar, carries an average stock price target met ratio of 35.5% that have a potential upside of 57.91% achieved within 128 days.
Emily Bodnar’s has documented 668 price targets and ratings displayed on 33 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on TGTX, TG Therapeutics at 06-Jul-2026.
Analyst best performing recommendations are on SQZ (SQZ BIOTECHNOLOGIES CO).
The best stock recommendation documented was for OLMA (OLEMA PHARMACEUTICALS) at 10/20/2025. The price target of $28 was fulfilled within 37 days with a profit of $20.23 (260.36%) receiving and performance score of 70.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Aug-2023
$48
$0.45 (0.95%)
$48
2 years 11 months 5 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold Since 26-Jun-2023
$56
3 years 18 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Buy Since 22-May-2023
$48
3 years 23 days ago
(21-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Buy Since 14-Sep-2022
$48
$0.45 (0.95%)
$68
3 years 24 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold Since 24-May-2023
$48
$0.45 (0.95%)
$38
3 years 24 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?